New drug combo offers hope for men with stubborn prostate symptoms
Disease control
Not yet recruiting
This study follows 600 men in South Korea with moderate to severe enlarged prostate symptoms that tamsulosin alone didn't control well. Researchers will track side effects and symptom improvement over 24 weeks of treatment with Vesomni, a combination tablet. The goal is to see ho…
Sponsor: Astellas Pharma Korea, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC